UNSPSC 51145100: Stimulant or anorexiant oxadiazoles

This classification denotes aromatic, heterocyclic compounds based on C2H2N2, substances called oxadiazoles, that increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term STIMULANT OR ANOREXIANT OXADIAZOLES.

UNSPSC 51145100 Stimulant or anorexiant oxadiazoles, a Class code, does not align with recent state and local procurement activity. The three opportunities posted under this code since April 2026 involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription program management (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and OTC products distributed through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations target oxadiazole compounds or stimulant/anorexiant medications as the code nominally describes. The mismatch suggests either tagging error in the source data or a significant divergence between the code's intended scope and how state and local procurement offices currently classify pharmaceutical supply contracts.

The represented issuing bodies span county health departments, state HHS commissions, and multistate cooperative purchasing alliances serving multiple jurisdictions and OTC needs. Recent activity appears concentrated in Florida, Texas, and Minnesota through the cooperative mechanism, though the source provides limited historical pattern data to characterize geographic or sectoral concentration across the full code. Firms pursuing pharmaceutical supply contracts with state and local governments should monitor the code's actual usage patterns rather than relying on its nominal classification; the recent solicitations suggest that procurement offices tag broad pharmaceutical supply and management services under this code regardless of specific active pharmaceutical ingredients.